Linoleic Acid Induced Angiopoietin-Like Protein 4 Impairs Skeletal Muscle Differentiation

被引:0
|
作者
Son, Yura
Paton, Chad
机构
[1] University of Georgia, Athens
来源
FASEB JOURNAL | 2022年 / 36卷
关键词
D O I
10.1096/fasebj.2022.36.S1.0R307
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Skeletal muscle differentiation is a pivotal process in embryonic development as well as regeneration/repair throughout the lifespan. It is well-known that dietary fat intake impacts biological and physiological function in skeletal muscle, however, understanding of the contribution of nutritional factors in skeletal muscle differentiation is limited. Thus, the objective of the current study is to evaluate the effects of fatty acids on skeletal muscle differentiation in vitro. Skeletal muscle differentiation is known to be regulated by Wnt/β-catenin signaling, and Wnt/β-catenin signaling is inhibited by angiopoietin-like protein 4 (ANGPTL4), a protein that is induced by free fatty acids (FFA). Therefore, the hypothesis of the current study is that FFA-induced ANGPTL4 inhibits skeletal muscle differentiation by suppressing Wnt/β-catenin signaling. We used C2C12 murine myoblasts and treated with various FFAs, recombinant ANGPTL4 protein, or siRNA knockdown of ANGPTL4 during cell differentiation. Among FFAs, 18:2n6 linoleic acid (LA) significantly inhibited myotube formation, showing decreased myoblast fusion. LA significantly lowered the protein expression of myogenic regulatory factors, including MyoD and MyoG and increased Pax7 during cell differentiation. We also confirmed that ANGPTL4 knockdown at day 2 and -6 of differentiation restored myotube formation in the presence of LA. Next, we performed an RNA-sequencing analysis to determine which pathways were involved in the mechanism of LA- and ANGPTL4-mediated inhibition of skeletal muscle differentiation at day 2 and -6 of differentiation. LA at day 2 and -6 and ANGPTL4 at day 2 downregulated Wnt/β-catenin signaling as well as genes involved in skeletal muscle differentiation. We further found that ANGPTL4 reduced β-catenin protein expression in nucleus, indicating that ANGPTL4 blocks β-catenin translocation into nucleus from cytoplasm, and it was restored with ANGPTL4 knockdown. Taken together, these results demonstrate that LA-induced ANGPTL4 inhibits skeletal muscle differentiation by suppressing Wnt/β-catenin signaling in C2C12 myoblasts. © FASEB.
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Regulation of the expression of angiopoietin-like protein 4 mRNA in diabetic mice
    Mizutani, N.
    Ozaki, N.
    Seino, Y.
    Fukuyama, T.
    Sakamoto, E.
    Oiso, Y.
    [J]. DIABETOLOGIA, 2009, 52 : S283 - S283
  • [32] Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD
    Waschki, Benjamin
    Kirsten, Anne
    Holz, Olaf
    Meyer, Thorsten
    Lichtinghagen, Ralf
    Rabe, Klaus
    Magnussen, Helgo
    Welte, Tobias
    Watz, Henrik
    Janciauskiene, Sabina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Knockdown of Angiopoietin-like protein 4 suppresses the development of colorectal cancer
    Wen, Liqiang
    Zhang, Yuchao
    Tan, Bin
    Han, Fanghai
    Ebadi, Abdol Ghaffar
    Toughani, Mohsen
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2020, 66 (05) : 117 - 124
  • [34] Angiopoietin-like 4, a protein strongly induced during sebocyte differentiation, regulates sebaceous lipogenesis but is dispensable for sebaceous gland function in vivo
    Dahlhoff, Maik
    Camera, Emanuela
    Picardo, Mauro
    Zouboulis, Christos C.
    Schneider, Marlon R.
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 75 (02) : 148 - 150
  • [35] Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
    Kevin Tak-Pan Ng
    Aimin Xu
    Qiao Cheng
    Dong Yong Guo
    Zophia Xue-Hui Lim
    Chris Kin-Wai Sun
    Jeffrey Hon-Sing Fung
    Ronnie Tung-Ping Poon
    Sheung Tat Fan
    Chung Mau Lo
    Kwan Man
    [J]. Molecular Cancer, 13
  • [36] Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
    Ng, Kevin Tak-Pan
    Xu, Aimin
    Cheng, Qiao
    Guo, Dong Yong
    Lim, Zophia Xue-Hui
    Sun, Chris Kin-Wai
    Fung, Jeffrey Hon-Sing
    Poon, Ronnie Tung-Ping
    Fan, Sheung Tat
    Lo, Chung Mau
    Man, Kwan
    [J]. MOLECULAR CANCER, 2014, 13
  • [37] Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndrome
    Kharazmi-Khorassani, Sara
    Kharazmi-Khorassani, Jasmin
    Rastegar-Moghadam, Azam
    Samadi, Sara
    Ghazizadeh, Hamideh
    Tayefi, Maryam
    Ferns, Gordon A.
    Ghayour-Mobarhan, Majid
    Avan, Amir
    Esmaily, Habibollah
    [J]. BMC MEDICAL GENETICS, 2019, 20
  • [38] Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor
    Inaba, T
    Matsuda, M
    Shimamura, M
    Takei, N
    Terasaka, N
    Ando, Y
    Yasumo, H
    Koishi, R
    Makishima, M
    Shimomura, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) : 21344 - 21351
  • [39] Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma
    El-Shal, Amal S.
    Zidan, Haidy E.
    Rashad, Nearmeen M.
    Wadea, Fady M.
    [J]. CYTOKINE, 2017, 96 : 75 - 86
  • [40] Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4
    Ge, HF
    Yang, GQ
    Yu, XX
    Pourbahrami, T
    Li, C
    [J]. JOURNAL OF LIPID RESEARCH, 2004, 45 (11) : 2071 - 2079